JP2008525359A5 - - Google Patents

Download PDF

Info

Publication number
JP2008525359A5
JP2008525359A5 JP2007547368A JP2007547368A JP2008525359A5 JP 2008525359 A5 JP2008525359 A5 JP 2008525359A5 JP 2007547368 A JP2007547368 A JP 2007547368A JP 2007547368 A JP2007547368 A JP 2007547368A JP 2008525359 A5 JP2008525359 A5 JP 2008525359A5
Authority
JP
Japan
Prior art keywords
mmol
solution
reaction mixture
cooled
stirred
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2007547368A
Other languages
English (en)
Japanese (ja)
Other versions
JP2008525359A (ja
Filing date
Publication date
Priority claimed from GBGB0428418.8A external-priority patent/GB0428418D0/en
Application filed filed Critical
Publication of JP2008525359A publication Critical patent/JP2008525359A/ja
Publication of JP2008525359A5 publication Critical patent/JP2008525359A5/ja
Pending legal-status Critical Current

Links

JP2007547368A 2004-12-24 2005-12-22 M3アンタゴニストとしての第4級アンモニウム塩類 Pending JP2008525359A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0428418.8A GB0428418D0 (en) 2004-12-24 2004-12-24 Organic compounds
PCT/EP2005/013897 WO2006066929A1 (en) 2004-12-24 2005-12-22 Quaternary ammonium salts as m3 antagonists

Publications (2)

Publication Number Publication Date
JP2008525359A JP2008525359A (ja) 2008-07-17
JP2008525359A5 true JP2008525359A5 (cg-RX-API-DMAC7.html) 2009-02-26

Family

ID=34130968

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2007547368A Pending JP2008525359A (ja) 2004-12-24 2005-12-22 M3アンタゴニストとしての第4級アンモニウム塩類

Country Status (16)

Country Link
US (1) US8153669B2 (cg-RX-API-DMAC7.html)
EP (1) EP1831208B1 (cg-RX-API-DMAC7.html)
JP (1) JP2008525359A (cg-RX-API-DMAC7.html)
KR (1) KR101259654B1 (cg-RX-API-DMAC7.html)
CN (1) CN101080405B (cg-RX-API-DMAC7.html)
AT (1) ATE521606T1 (cg-RX-API-DMAC7.html)
AU (1) AU2005318424B2 (cg-RX-API-DMAC7.html)
BR (1) BRPI0519292A2 (cg-RX-API-DMAC7.html)
CA (1) CA2589133A1 (cg-RX-API-DMAC7.html)
ES (1) ES2370832T3 (cg-RX-API-DMAC7.html)
GB (1) GB0428418D0 (cg-RX-API-DMAC7.html)
MX (1) MX2007007722A (cg-RX-API-DMAC7.html)
PL (1) PL1831208T3 (cg-RX-API-DMAC7.html)
PT (1) PT1831208E (cg-RX-API-DMAC7.html)
RU (1) RU2394031C2 (cg-RX-API-DMAC7.html)
WO (1) WO2006066929A1 (cg-RX-API-DMAC7.html)

Families Citing this family (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0428416D0 (en) 2004-12-24 2005-02-02 Novartis Ag Organic compounds
KR101495708B1 (ko) 2007-02-23 2015-02-25 세라밴스 바이오파마 알앤디 아이피, 엘엘씨 무스카린 수용체 안타고니스트로 유용한 4차 암모늄 디페닐메틸 화합물
MX2010002576A (es) 2007-09-07 2010-04-01 Theravance Inc Compuestos que contienen guanidina, utiles como antagonistas de los receptores muscarinicos.
EP2222637A1 (en) 2007-12-14 2010-09-01 Theravance, Inc. Amidine-containing compounds useful as muscarinic receptor antagonists
DE102008020746A1 (de) 2008-04-25 2009-10-29 Saltigo Gmbh Verfahren zur Herstellung von quarternären Salzen von Piperidyl Estern der Mandelsäure
EP2935249B1 (en) 2012-12-19 2018-12-12 Novartis AG Autotaxin inhibitors
JP6223543B2 (ja) 2013-03-15 2017-11-01 ボドール ラボラトリーズ, インコーポレイテッド 多汗症の処置のための抗コリン作用性グリコピロレートエステル
US20160368873A1 (en) * 2014-02-17 2016-12-22 Ltt Bio-Pharma Co., Ltd. Optically Active Form of Mepenzolate, and Ameliorating Agent for Chronic Obstructive Pulmonary Disease Which Contains Same as Active Ingredient
US20150259283A1 (en) 2014-03-13 2015-09-17 Brickell Biotech, Inc. Formulation for soft anticholinergic analogs
EP3134398A1 (en) 2014-04-24 2017-03-01 Novartis Ag Autotaxin inhibitors
US10472664B2 (en) 2014-10-03 2019-11-12 Institute For Cancer Research Screening assay for identification of poly(ADP-ribose) polymerase 1 inhibitors
EP3200792A4 (en) 2014-10-03 2018-05-09 The Institute for Cancer Research d/b/a The Research Institute of Fox Chase Cancer Center Poly (adp-ribose) polymerase 1 inhibitors structurally unrelated to nad
HK1253236A1 (zh) 2015-07-21 2019-06-14 博多尔实验仪器公司 软性抗胆碱能药类似物的制剂
TWI719046B (zh) 2016-07-21 2021-02-21 美商波德實驗股份有限公司 軟性抗膽鹼類似物之製劑
US11377422B2 (en) 2019-03-11 2022-07-05 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
CA3155568A1 (en) 2019-11-06 2021-05-14 Bridget Mccarthy Cole Charged ion channel blockers and methods for use
US11332446B2 (en) * 2020-03-11 2022-05-17 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use
US12162851B2 (en) 2020-03-11 2024-12-10 Nocion Therapeutics, Inc. Charged ion channel blockers and methods for use

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2746966A (en) * 1953-11-02 1956-05-22 Lakeside Lab Inc Esters of bis-(nu-substituted-3-hydroxypiperidinium) alkanes
GB833820A (en) * 1957-10-17 1960-04-27 Beecham Res Lab Improvements in or relating to the preparation of pyrrolidyl esters and quaternary compounds thereof
US2956062A (en) * 1959-02-26 1960-10-11 Robins Co Inc A H Esters of amino alcohols
JPS6018661B2 (ja) 1976-01-01 1985-05-11 太田製薬株式会社 1−(1,3−ジオキソラン−4−イルメチル)ピペリジノ−ル誘導体
JPS5427570A (en) 1977-07-30 1979-03-01 Ota Pharma Stereoisomer of 44acyloxyy11 alkyll11*1*33dioxolanee44 ylmethyl* pideridinium salt derivative
JPS5679688A (en) 1979-12-04 1981-06-30 Ota Seiyaku Kk 4-acyloxy-1- 1,3-dioxoran-2-ylmethyl piperidine derivative and its production
JPS5835177A (ja) * 1981-08-26 1983-03-01 Dainippon Pharmaceut Co Ltd 2−環状アミノ−2−(1,2−ベンズイソキサゾ−ル−3−イル)酢酸エステル類並びにその酸付加塩類および第4級アンモニウム塩類
JPS58208270A (ja) 1982-05-28 1983-12-03 Dainippon Pharmaceut Co Ltd α−環状アミノフエニル酢酸エステル類並びにその酸付加塩類及び第4級アンモニウム塩類
GB9023023D0 (en) 1990-10-23 1990-12-05 Barlow Richard B Pharmaceutical compositions
SI0937041T1 (en) 1996-11-11 2003-10-31 Christian R. Noe Use of a pharmaceutically acceptable salt of (3R,2'R)-3-((Cyclopently-hydroxyphenylacetyl)oxy)-1,1-dimethyl-pyrrolidinium for the preparation of a medicament
EP1302458A4 (en) 2000-07-11 2005-10-19 Banyu Pharma Co Ltd ESTERDERIVATE
ES2206021B1 (es) 2002-04-16 2005-08-01 Almirall Prodesfarma, S.A. Nuevos derivados de pirrolidinio.
WO2004056767A1 (en) * 2002-12-23 2004-07-08 Ranbaxy Laboratories Limited 1-substituted-3-pyrrolidine derivatives as muscarinic receptor antagonists
PE20050231A1 (es) * 2003-06-24 2005-05-20 Novartis Ag Derivados de piperidinium y pirrolidinium como antagonistas del receptor muscarinico m3
EP1781607A2 (en) * 2004-08-19 2007-05-09 Ranbaxy Laboratories Limited Pyrrolidine derivatives as muscarinic receptor antagonists

Similar Documents

Publication Publication Date Title
JP2006512301A5 (cg-RX-API-DMAC7.html)
JP2010520228A5 (cg-RX-API-DMAC7.html)
KR101329112B1 (ko) (3r,5r)-7-〔2-(4-플루오로페닐)-5-이소프로필-3-페닐-4-〔(4-히드록시 메틸 페닐 아미노)카르보닐〕-피롤-1-일〕-3,5-디히드록시 헵탄산 헤미 칼슘염의 제조 방법
JP2008523130A5 (cg-RX-API-DMAC7.html)
JP2549609B2 (ja) 置換ピペリジンの光学分割法
MXPA02006415A (es) Procedimiento para preparar tolterodina y analogos de la misma asi como los intermediarios preparados en el procedimiento.
TW201434851A (zh) 合成e1活化酶抑制劑之方法
RU2101279C1 (ru) Способ получения производных (s)-3-амино-1-бензил-пирролидина, производные (s)-азиридина в качестве промежуточных соединений для их синтеза и 1-бензил-3-(s)-[2-(s)-(трет-бутоксикарбониламино)пропиониламино]-пирролидин в качестве промежуточного продукта для синтеза антибактериальных агентов на основе хинолона
US8378119B2 (en) Method for producing asymmetric tetrasubstituted carbon atom-containing compound
US4501901A (en) Method for making substituted prolines
SK14799A3 (en) Process for the preparation of 2-aryl-5-(perfluoroalkyl)pyrrole compounds from n-(perfluoroalkylmethyl)arylimidoyl chloride compounds
JP2000247980A (ja) (−)ピリドベンゾオキサジンカルボン酸誘導体の製造方法
KR101032600B1 (ko) 고순도 레바미피드의 제조방법
JP2008290969A (ja) アミノアセチルピロリジン誘導体の製造方法
JPWO1998047867A1 (ja) アゼチジン−2−カルボン酸及びその中間体の製造方法
JP4484525B2 (ja) ニューロテンシン活性2,3−ジアリール−ピラゾリジン誘導体
JP2008239543A (ja) ビシクロアミノアセチルピロリジンカルボニトリル誘導体の製造方法およびその製造中間体
CN104292293B (zh) 一种度他雄胺杂质i的制备方法
JP2022008191A (ja) tert-ブチル N-((1R,2S,5S)-2-((2-((5-クロロピリジン-2-イル)アミノ)-2-オキソアセチル)アミノ)-5-(ジメチルカルボニル)シクロヘキシル)カルバメートの調製のための方法
US5466828A (en) Chiral 3-cyano-1-substituted-pyrrolidines
US20070129547A1 (en) Process to prepare substituted imidazopyrazine compounds
JP4057088B2 (ja) ピロリジン誘導体の製造方法
WO2013027835A1 (ja) 光学活性ナフタレン化合物の製法
JP5236627B2 (ja) 不斉四置換キノロンカルボン酸の製造方法およびその製造中間体
JP2000026408A (ja) 対掌体的に純粋なピロリジン誘導体、その塩、それらの製造方法